4Baddley JW, Stroud TP, Salzman D, et al.Invasive mold infections in allogeneic bone marrow transplant recip ients [J].Clin Infect Dis, 2001,32(9):1319- 1324.
5Kan L W,Lin JD.Management of Systemic Candidal Infections in the Intensive Care Unit[J].AMJ Health Syst Pharm,2002,59(5):33-41.
6Kuderer NM,Dale DC,Crawf.rd J,et al.Mortality,morbidity,and cost associated with febrile neutropenia in adult eancer patients [J].Cancer,2006,106 (10):2258- 2266.
7BoogaertsM, Winston DJ, Bow EJ, et al.lntravenous and oral itraconazole versus intravenous amphotericin b-deoxycholate as emp irical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broadspectrum antibacterial therapyl A randomized, controlled trial [J]. Ann Intern Med, 2001, 135(6): 412-422.
8Dean D, Burchard KW. Fungal infection in surgical patients[J]. Am J Surg,1996,171:374.
9Ehninger G, Schuler HK, Sarnow E. Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation[J].Mycoses, 1996,39 : 259.
10Bow EJ. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer [J]. Br J Haematol,1998,101(Suppl 1):1- 4.
